Novartis Oncology Universal Co-pay Program: Kisqali

Funded

About

The Novartis Oncology Universal Co-pay Program: Kisqali offers substantial financial assistance to eligible patients using the drug Kisqali. Designed for those with private insurance in the U.S. and Puerto Rico, the program ensures that patients pay no more than $25 per month while covering up to $15,000 annually. With automatic re-enrollment each year, the program provides ongoing support without the burden of high out-of-pocket costs, making Kisqali more accessible to those who need it.

Insurance requirements: Commercially insured

As low as: $25 per mo

Enrollment Forms

Enrollment Form

Benefits

•$15000 annual maximum benefit

•12 maximum fills per year

Program Requirements

•Valid only for residents in the US and Puerto Rico

•Enrollment Required: Yes

•Coverage Required: No

•Needs Based: No

•Activation Required: No

Program Details

•Commercially insured patients pay no more than $25 per month; program pays up to $15,000 per calendar year

•Card can be printed for immediate use following online eligibility questions and registration

•Offer may not be combined with any other rebate, coupon, or other offer(s)

•Patient automatically reenrolled on the 1st of each calendar year if commercial insurance remains active and covers drug (Novartis copay cards DO NOT EXPIRE)

Enrollment Forms

Enrollment Form